Showing results (241-250 of 294) with videos related to

Sort By:
Pageof 30
European Journal of Dermatology : EJD|January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Karen Bartley, Thomas Karagiannis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2025
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA studySalvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective StudySilvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
The Oncologist|May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Cells|October 14, 2022
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck CancerStefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, et al.
Frontiers in Oncology|October 2, 2023
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructureLaura Botta, Tomohiro Matsuda, Hadrien Charvat, et al.
Plos One|July 30, 2020
Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapySimon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
Critical Reviews in Oncology/Hematology|July 5, 2015
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensusAntonio Schindler, Nerina Denaro, Elvio G Russi, et al.
Plos One|May 23, 2020
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapySimon Keek, Sebastian Sanduleanu, Frederik Wesseling, et al.
Journal for Immunotherapy of Cancer|September 8, 2025
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancerCaroline Even, Kevin J Harrington, Erminia Massarelli, et al.
Pageof 30